Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 4107112)

Published in Gastroenterology on April 22, 2014

Authors

Bridget K Butz1, Ting Wen1, Gerald J Gleich2, Glenn T Furuta3, Jonathan Spergel4, Eileen King5, Robert E Kramer3, Margaret H Collins6, Emily Stucke1, Colleen Mangeot5, W Daniel Jackson7, Molly O'Gorman7, J Pablo Abonia1, Scott Pentiuk8, Philip E Putnam8, Marc E Rothenberg9

Author Affiliations

1: Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
2: Department of Dermatology, Department of Medicine, School of Medicine, University of Utah, Salt Lake City, Utah.
3: Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
4: Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
5: Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
6: Division of Pathology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
7: Division of Pediatric Gastroenterology, University of Utah, Salt Lake City, Utah.
8: Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
9: Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio. Electronic address: rothenberg@cchmc.org.

Associated clinical trials:

A Study of Flovent in Patients With Eosinophilic Esophagitis | NCT00426283

EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone | NCT03781596

Articles citing this

Advances in clinical management of eosinophilic esophagitis. Gastroenterology (2014) 1.48

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut (2015) 1.13

Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology (2015) 1.11

Eosinophilic Esophagitis. N Engl J Med (2015) 1.07

Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol (2015) 1.00

Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol (2015) 0.91

Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunol Allergy Clin North Am (2015) 0.87

Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. Clin Gastroenterol Hepatol (2015) 0.86

The esophageal biopsy "pull" sign: a highly specific and treatment-responsive endoscopic finding in eosinophilic esophagitis (with video). Gastrointest Endosc (2015) 0.86

Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus (2016) 0.86

Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis. Am J Gastroenterol (2016) 0.85

White Paper AGA: Eosinophilic Esophagitis. Clin Gastroenterol Hepatol (2017) 0.85

Management of Eosinophilic Esophagitis During Pregnancy. Dig Dis Sci (2016) 0.81

Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol (2015) 0.81

Early Comparison of Inflammatory vs. Fibrostenotic Phenotype in Eosinophilic Esophagitis in a Multicenter Longitudinal Study. Clin Transl Gastroenterol (2015) 0.80

Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients. Aliment Pharmacol Ther (2017) 0.79

An Overview of the Diagnosis and Management of Eosinophilic Esophagitis. Clin Transl Gastroenterol (2016) 0.78

Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis. Dig Dis Sci (2016) 0.77

The Immunologic Mechanisms of Eosinophilic Esophagitis. Curr Allergy Asthma Rep (2016) 0.77

Wheat allergy: diagnosis and management. J Asthma Allergy (2016) 0.77

Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis. Aliment Pharmacol Ther (2016) 0.77

Topical glucocorticoid vs. diet therapy in eosinophilic esophagitis: the need for better treatment options. Expert Rev Clin Immunol (2016) 0.75

A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults. Clin Transl Gastroenterol (2017) 0.75

Determination of esophageal eosinophil counts and other histologic features of eosinophilic esophagitis by pathology trainees is highly accurate. Hum Pathol (2016) 0.75

Managing eosinophilic esophagitis: challenges and solutions. Clin Exp Gastroenterol (2016) 0.75

Cost Utility Analysis of Topical Steroids Compared to Dietary Elimination for Treatment of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol (2016) 0.75

Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches. Expert Rev Gastroenterol Hepatol (2015) 0.75

Therapeutic strategies in eosinophilic esophagitis: Induction, maintenance and refractory disease. Best Pract Res Clin Gastroenterol (2015) 0.75

Recent discoveries and emerging therapeutics in eosinophilic esophagitis. World J Gastrointest Pharmacol Ther (2016) 0.75

Eosinophilic Esophagitis in Children and Adolescents with Abdominal Pain: Comparison with EoE-Dysphagia and Functional Abdominal Pain. Can J Gastroenterol Hepatol (2016) 0.75

Management of refractory eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2017) 0.75

Clinical Applications of the Eosinophilic Esophagitis Diagnostic Panel. Front Med (Lausanne) (2017) 0.75

Current Diagnostic and Treatment Strategies for Eosinophilic Esophagitis. Gastroenterol Hepatol (N Y) (2017) 0.75

Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression. Dig Dis Sci (2017) 0.75

Diminishing Effectiveness of Long-Term Maintenance Topical Steroid Therapy in PPI Non-Responsive Eosinophilic Esophagitis. Clin Transl Gastroenterol (2017) 0.75

Articles cited by this

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology (2007) 9.05

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol (2013) 5.09

Eosinophilic esophagitis. N Engl J Med (2004) 4.43

Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula. Aliment Pharmacol Ther (2012) 3.91

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology (2006) 3.68

An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest (2001) 3.32

Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology (2012) 3.29

IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol (2007) 3.24

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology (2010) 2.76

Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2011) 2.70

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology (2002) 2.52

Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet (2010) 2.47

Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology (2010) 2.29

Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr (1998) 2.05

Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96

Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol (2004) 1.87

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy (2009) 1.64

Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol (2010) 1.63

Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic--pituitary--adrenal axis activity. Clin Endocrinol (Oxf) (2005) 1.53

Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology (2013) 1.51

Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2009) 1.44

Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol (2012) 1.16

Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications. Clin Endocrinol (Oxf) (2012) 1.04

Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. J Allergy Clin Immunol (2012) 1.02

The management of eosinophilic esophagitis. J Allergy Clin Immunol Pract (2013) 0.91

Fluticasone in eosinophilic corrugated ringed esophagus. Am J Gastroenterol (2001) 0.89

Dysphagia and quality of life may improve with mometasone treatment in patients with eosinophilic esophagitis: a pilot study. Otolaryngol Head Neck Surg (2011) 0.81

Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. J Allergy Clin Immunol (2012) 0.81